Buprenorphine

Buprenorphine is a partial opioid agonist used for the treatment of opioid use disorder, moderate-to-severe chronic pain, and as an analgesic. Its ceiling effect on respiratory depression makes it safer than full opioid agonists. Mediocon Inc supplies pharmaceutical-grade Buprenorphine meeting IP/BP/EP/USP standards.

Key Features

• Partial opioid mu-receptor agonist
• IP/BP/EP/USP compliant quality
• Opioid use disorder and pain management
• Suitable for sublingual, transdermal, and injectable formulations

Applications

• Sublingual tablets for opioid dependence
• Transdermal patches for pain
• Injectable formulations
• Buccal films and strips

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings